RORC2 inverse agonist 66 [PMID: 30130103]   Click here for help

GtoPdb Ligand ID: 10078

Synonyms: example 5 [WO2016046755A1]
Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: This compound is reported as an orally active, inverse agonist of the nuclear hormone receptor RORγt (RORC2) [2]. RORγt is a drug target that is being expoited for the treatment of autoimmune conditions, as its inhibition reduces production of pro-inflammatory IL-17. The chemical structure is claimed as Example 5 in Pfizer's patent WO2016046755A1 [1].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 1
Rotatable bonds 7
Topological polar surface area 91.02
Molecular weight 497.2
XLogP 4.15
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES N#Cc1cccc(c1)C(=O)Nc1cnc2c(c1C(F)(F)F)c(cn2C)C1CCN(CC1)C(=O)C(C)C
Isomeric SMILES N#Cc1cccc(c1)C(=O)Nc1cnc2c(c1C(F)(F)F)c(cn2C)C1CCN(CC1)C(=O)C(C)C
InChI InChI=1S/C26H26F3N5O2/c1-15(2)25(36)34-9-7-17(8-10-34)19-14-33(3)23-21(19)22(26(27,28)29)20(13-31-23)32-24(35)18-6-4-5-16(11-18)12-30/h4-6,11,13-15,17H,7-10H2,1-3H3,(H,32,35)
InChI Key BIHPJIJLDNUDGH-UHFFFAOYSA-N
References
1. Flick AC, Jones P, Kaila N, Mente SR, Schnute ME, Trzupek JD, Vazquez ML, Xing L, Zhang L, Wennerstal GM et al.. (2016)
Methyl-and trifluoromethyl-substituted pyrrolopyridine modulators of rorc2 and methods of use thereof.
Patent number: WO2016046755A1. Assignee: Pfizer Inc.. Priority date: 26/09/2014. Publication date: 31/03/2016.
2. Schnute ME, Wennerstål M, Alley J, Bengtsson M, Blinn JR, Bolten CW, Braden T, Bonn T, Carlsson B, Caspers N et al.. (2018)
Discovery of 3-Cyano- N-(3-(1-isobutyrylpiperidin-4-yl)-1-methyl-4-(trifluoromethyl)-1 H-pyrrolo[2,3- b]pyridin-5-yl)benzamide: A Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor C2 Inverse Agonist.
J Med Chem, 61 (23): 10415-10439. [PMID:30130103]